New cardiac platform for the management of cardiovascular risk following preeclampsia using in vitro bioengineered cardiac spheroids and patient-derived stem cells

McClements, L; Ming, CLC; Pienaar, D; Ghorbanpour, S; Roberts, LM; Henry, A; McGrath, DK; Ortega, DG; Gentile, C

New cardiac platform for the management of cardiovascular risk following preeclampsia using in vitro bioengineered cardiac spheroids and patient-derived stem cells

McClements, L

Ming, CLC Pienaar, D Ghorbanpour, S Roberts, LM Henry, A McGrath, DK Ortega, DG Gentile, C

Permalink

Publisher:: Elsevier
Publication Type:: Conference Abstract
Citation:: Pregnancy Hypertension, 2024, 36, pp. 35-36
Issue Date:: 2024-08

Closed Access

	Filename	Description	Size
	1-s2.0-S2210778924000746-main.pdf	Published version	66.18 kB	Adobe PDF	View/Open

Copyright Clearance Process

Recently Added
In Progress
Closed Access

This item is closed access and not available.

Full metadata record

Field	Value	Language
dc.contributor.author	McClements, L https://orcid.org/0000-0002-4911-1014
dc.contributor.author	Ming, CLC
dc.contributor.author	Pienaar, D
dc.contributor.author	Ghorbanpour, S
dc.contributor.author	Roberts, LM
dc.contributor.author	Henry, A
dc.contributor.author	McGrath, DK
dc.contributor.author	Ortega, DG
dc.contributor.author	Gentile, C https://orcid.org/0000-0002-3689-4275
dc.date.accessioned	2025-01-06T00:37:18Z
dc.date.available	2025-01-06T00:37:18Z
dc.date.issued	2024-08
dc.identifier.citation	Pregnancy Hypertension, 2024, 36, pp. 35-36
dc.identifier.issn	2210-7789
dc.identifier.uri	http://hdl.handle.net/10453/182984
dc.language	en
dc.publisher	Elsevier
dc.relation	Maridulu Budyari Gumal - The Sydney Partnership for Health, Education, Research and Enterprise (SPHERE)
dc.relation.ispartof	Pregnancy Hypertension
dc.relation.isbasedon	10.1016/j.preghy.2024.01.074
dc.rights	info:eu-repo/semantics/closedAccess
dc.subject	1114 Paediatrics and Reproductive Medicine
dc.subject.classification	3215 Reproductive medicine
dc.title	New cardiac platform for the management of cardiovascular risk following preeclampsia using in vitro bioengineered cardiac spheroids and patient-derived stem cells
dc.type	Conference Abstract
utslib.citation.volume	36
utslib.for	1114 Paediatrics and Reproductive Medicine
pubs.organisational-group	University of Technology Sydney
pubs.organisational-group	University of Technology Sydney/Faculty of Engineering and Information Technology
pubs.organisational-group	University of Technology Sydney/Faculty of Science
pubs.organisational-group	University of Technology Sydney/Faculty of Science/School of Life Sciences
pubs.organisational-group	University of Technology Sydney/Faculty of Engineering and Information Technology/School of Biomedical Engineering
pubs.organisational-group	University of Technology Sydney/UTS Groups
pubs.organisational-group	University of Technology Sydney/UTS Groups/Centre for Health Technologies (CHT)
pubs.organisational-group	University of Technology Sydney/UTS Groups/Institute of Biomedical Materials and Devices (IBMD)
pubs.organisational-group	University of Technology Sydney/UTS Groups/Institute of Biomedical Materials and Devices (IBMD)/Institute of Biomedical Materials and Devices (IBMD) Associate Members
utslib.copyright.status	closed_access	*
dc.date.updated	2025-01-06T00:37:17Z
pubs.publication-status	Published
pubs.volume	36

Please use this identifier to cite or link to this item:

http://hdl.handle.net/10453/182984